rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

William J. Sharbaugh

Director

Company insider

Files Form 4 as: Director, Fortrea Holdings; Chief Operating Officer, Ppd; Chief Operating Officer, Pharmaceutical Product Development.

Every Form 4 they filed

In numbers

Trades disclosed
48
Buys
1
Sells
0
Bought
$810K
Sold
$0
Companies
3
Companies where not an officer
1
First trade
31 May 2007
Last trade
10 Jun 2026
Last filed
12 Jun 2026

Companies traded

Where they are an officer
PpdOfficer · last 8 Dec 20211 buy · 0 sells
Pharmaceutical Product DevelopmentOfficer · last 5 Dec 20110 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
FTRE Fortrea HoldingsDirector · Diagnostics & Labs · last 10 Jun 20260 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
10 Jun 2026filed 12 Jun 2026FTRE Fortrea Holdingsoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—12,852 at $0.00filing
10 Jun 2026filed 12 Jun 2026FTRE Fortrea Holdingsoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—12,852 at $0.00filing
20 Nov 2025filed 24 Nov 2025FTRE Fortrea Holdingsoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—20,916 at $0.00filing
8 Dec 2021filed 8 Dec 2021Ppdoption or derivativeSEC FORM 4 Code D$21.0M646,604 at $32.45filing
8 Dec 2021filed 8 Dec 2021Ppdoption or derivativeSEC FORM 4 Code A—93,038 at $0.00filing
8 Dec 2021filed 8 Dec 2021Ppdoption or derivativeSEC FORM 4 Code D$20.3M549,582 at $36.91filing
8 Dec 2021filed 8 Dec 2021Ppdoption or derivativeSEC FORM 4 Code D—48,408filing
8 Dec 2021filed 8 Dec 2021PpdSEC FORM 4 Code D$18.0M378,005 at $47.50filing
8 Dec 2021filed 8 Dec 2021PpdSEC FORM 4 Code D$3.5M74,480 at $47.50filing
8 Dec 2021filed 8 Dec 2021PpdSEC FORM 4 Code A—42,424 at $0.00filing
8 Dec 2021filed 8 Dec 2021PpdSEC FORM 4 Code D—42,424filing
11 Feb 2021filed 16 Feb 2021Ppdoption or derivativeSEC FORM 4 Code A—102,341 at $0.00filing
11 Feb 2021filed 16 Feb 2021Ppdoption or derivativeSEC FORM 4 Code A—48,408 at $0.00filing
19 Feb 2020filed 21 Feb 2020Ppdoption or derivativeSEC FORM 4 Code A—88,384 at $0.00filing
10 Feb 2020filed 12 Feb 2020PpdSEC FORM 4 Code D—332,485filing
10 Feb 2020filed 12 Feb 2020PpdSEC FORM 4 Code A—332,485filing
10 Feb 2020filed 12 Feb 2020PpdSEC FORM 4 Code D—90,000filing
10 Feb 2020filed 12 Feb 2020PpdSEC FORM 4 Code A—90,000filing
10 Feb 2020filed 12 Feb 2020PpdSEC FORM 4 Bought$810K30,000 at $27.00filing
5 Dec 2011filed 6 Dec 2011Pharmaceutical Product Developmentoption or derivativeSEC FORM 4 Code D—45,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed1

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.